A pilot study of rat brain regional distribution of calcitonin, katacalcin and calcitonin gene-related peptide before and after antipsychotic treatment

Neuropeptides

Volumn 35, Issue 5-6, 2001, Pages 285-291

  Angelucci, F ^a,b   Gruber, S H M ^a   Mathe A A ^a  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; HALOPERIDOL; KATACALCIN; NEUROLEPTIC AGENT; RISPERIDONE; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MICROWAVE IRRADIATION; NERVE CELL; NEUROCHEMISTRY; NONHUMAN; OCCIPITAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RADIOIMMUNOASSAY; ANIMAL; BLOOD; DRUG EFFECT; HUMAN; METABOLISM; METHODOLOGY; MICROWAVE RADIATION; PILOT STUDY; RANDOMIZATION; RAT; WISTAR RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; HALOPERIDOL; HUMANS; MALE; MICROWAVES; PEPTIDE FRAGMENTS; PILOT PROJECTS; RADIOIMMUNOASSAY; RANDOM ALLOCATION; RATS; RATS, WISTAR; RISPERIDONE;

EID: 0035545179     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2001.0876     Document Type: Article

References (49)

1. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products
2. Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyltransferase in rat brain regions
3. Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered following haloperidol and risperidone administration
4. Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat
5. 3′,5′ cyclic adenosine monophosphate mediates the salmon calcitonin-induced increase in hypothalamic tyrosine hydroxylase activity
6. Activation of cultured rat hypothalamic dopaminergic neurons by long-term but not short-term treatment with prolactin
7. Evaluation of sensitive PDN-21 (katacalcin) determination as tumour marker in medullary thyroid carcinoma
8. Use of calcitonin in psychotic agitation or mania
9. Effects of calcitonin gene-related peptide on extrapyramidal motor system
10. Evidence for calcitonin-a new hormone from the parathyroid that lowers blood calcium
11. Calcitonin gene-related peptide in the ventral tegmental area: Selective modulation of prefrontal cortical dopamine metabolism
12. a
13. Novel Peptides from the Calcitonin Gene: Expression, Receptors and Biological Function
14. Characterization and regional distribution of calcitonin binding sites in the rat brain
15. Calcitonin: Regional distribution of the hormone and its binding sites in the human brain and pituitary
16. Presence of immunoreactive calcitonin in the hypothalamus and pituitary lobes of rats
17. New antipsychotics: Classification, efficacy, and adverse effects
18. Regional studies of catecholamines in the rat brain: The disposition of (3H) norepinerphine, (3H) dopamine and (3H) dopa in various regions of the brain
19. Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum
20. Effects of amphetamine and dopamine receptor antagonists on calcitonin gene-related peptide, neuropeptide Y and neurotensin in rat brain
21. Dopamine receptor antagonists prevent the d-amphetamine-induced increase in calcitonin gene-related peptide levels in the ventral striatum
22. Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat
23. Effects of d-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat
24. Katacalcin: A new plasma calcium-lowering hormone
25. Purification of calcitonin-like peptides from rat brain and pituitary
26. Calcitonin gene-related peptide in the nervous tissue
27. Structure-activity analysis of CGRP's neurobehavioral effects
28. Effect of calcitonin gene-related peptide on passive avoidance behavior in rats. Role of transmitters
29. Effects of CGRP on active avoidance behavior in rats
30. Neurotransmitter-mediated open-field behavioral action of CGRP
31. A second plasma calcium-lowering peptide from the human calcitonin precursor- a re-evaluation
32. Effects of electroconvulsive stimuli and MK-801 on Neuropeptide Y, Neurokinin A, and Calcitonin Gene-Related Peptide in rat brain
33. The psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the rat
34. Microdialysis of extracellular neurotensin and calcitonin gene-related peptide from the rat brain: Effects of d-amphetamine and phencyclidine
35. Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brain
36. Neuropeptides in brain: Effects of microwave irradiation and decapitation
37. Neurotensin, antipsychotic drugs and schizophrenia: Basic and clinical studies
38. Effects of calcitonin on rat extrapyramidal motor system: Behavioral and biochemical data
39. Calcitonin and PDN-21 as tumour markers in men-2 family screening for medullary thyroid carcinoma
40. Biologically active salmon calcitonin-like peptide is present in rat brain
41. Structure and expression of the human calcitonin/CGRP genes
42. Microwave irradiation increases recovery of neuropeptides from brain tissues
43. Calcitonin depresses amphetamine-induced locomotor activity
44. Motor effects of calcitonin administered intracerebroventricularly in the rat
45. Antagonist behavioral effects of calcitonin and amphetamine in the rat
46. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors
47. Calcitonin and bipolar disorder: A hypothesis revisited
48. Calcitonin gene-relate peptide and its receptors: Molecular genetics, physiology, pathophysiology, and therapeutic potentials
49. Amylin, calcitonin gene-relate peptide, calcitonin, and adrenomedullin: A peptide superfamily